BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6883717)

  • 1. Effect of protamine sulfate on antithrombin III activity.
    Matsuo T; Shanberge JN; Matsuo O
    Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
    Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN; Quattrociocchi-Longe TM
    Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on neutralization of low molecular weight heparin (LHG) by protamine sulfate and its neutralization characteristics.
    Sugiyama T; Itoh M; Ohtawa M; Natsuga T
    Thromb Res; 1992 Oct; 68(2):119-29. PubMed ID: 1335615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
    Preissner KT; Delvos U; Müller-Berghaus G
    Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of heparin and LMW heparin on hemostasis.
    Hirsh J; Buchanan MR
    Thromb Res Suppl; 1991; 14():11-7. PubMed ID: 1658966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
    Shanberge JN; Quattrociocchi-Longe TM; Martens MH
    Thromb Res; 1987 Apr; 46(1):89-100. PubMed ID: 3590116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A method of determining heparin in blood plasma based on its antithrombin activity].
    Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI
    Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of protein-bound heparin and antithrombin III.
    Shanberge JN; Sridhar CN
    Ann N Y Acad Sci; 1981; 370():708-13. PubMed ID: 6168228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of polycations on the inhibitory action of antithrombin III on thrombin in the absence and presence of polyanions.
    Schiele U; Heuck CC
    Thromb Res; 1986 Jul; 43(2):187-93. PubMed ID: 3738858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
    Teoh KH; Young E; Bradley CA; Hirsh J
    Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of thrombin/antithrombin III reaction in the presence of protamine or polybrene.
    Oshima G
    Thromb Res; 1988 Sep; 51(6):565-74. PubMed ID: 3187966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of a bacterial glycopeptide.
    Akoum A; Josefonvicz J; Sigot M
    Thromb Res; 1990 Oct; 60(1):9-18. PubMed ID: 2126150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
    Brecher AS; Roland AR
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
    Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
    Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.